Zhaoxing Sun

Zhaoxing Sun

Auto-generated profile, based on publicly available information

Zhaoxing Sun

Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in European Journal of Pharmacology
Verified
Journal Article
Closed access
SCShasha Cai
Shasha Cai
CLChangao Lu
Changao Lu
ZLZhenlei Liu
Zhenlei Liu
WWWenbo Wang
Wenbo Wang
SLShuxin Lu
Shuxin Lu
GWGuannan Wang
Guannan Wang

9 September 2021 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
SXSujuan Xu
Sujuan Xu
ELEdward Lee
Edward Lee
ZSZhaoxing Sun
Zhaoxing Sun
XWXiaoyan Wang
Xiaoyan Wang
TRTing Ren
Ting Ren
XDXiaoqiang Ding
Xiaoqiang Ding
Renal ischemia-reperfusion (I/R) can induce oxidative stress and injury via the generation of reactive oxygen species (ROS). Renal proximal tubular cells are susceptible to oxidative stress, and the dysregulation of renal proximal tubular cellular homeostasis can damage cells via apoptotic pathways. A recent study showed that the generation of ROS can increase perilipin 2 (Plin2) expression in HepG2 cells. Some evidence has also demonstrated the association between Plin2 expression and renal tumors. However, the underlying mechanism of Plin2 in I/R-induced acute kidney injury (AKI) remains elusive. Here, using a mouse model of I/R-induced AKI, we found that ROS generation was increased and the expression of Plin2 was significantly upregulated. An in vitro study further revealed that the expression of Plin2, and the generation of ROS were significantly upregulated in primary tubular cells treated with hydrogen peroxide. Accordingly, Plin2 knockdown decreased apoptosis in renal proximal tubular epithelial cells treated with hydrogen peroxide, which depended on the activation of peroxisome proliferator-activated receptor α (PPARα). Overall, the present study demonstrated that Plin2 is involved in AKI; knockdown of this marker might limit apoptosis via the activation of PPARα. Consequently, the downregulation of Plin2 could be a novel therapeutic strategy for AKI.